Halozyme Therapeutics
HALO
#2434
Rank
C$10.07 B
Marketcap
C$85.71
Share price
-1.61%
Change (1 day)
23.28%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2025 (TTM): C$1.04 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are C$1.24 Billion. In 2024 the company made an earning of C$0.77 Billion, an increase over its 2023 earnings that were of C$0.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$1.04 B35.57%
2024 C$0.77 B59.94%
2023 C$0.48 B39.94%
2022 C$0.34 B0.16%
2021 C$0.34 B92.2%
2020 C$0.17 B-278.96%
2019 -C$0.11 Billion-9.45%
2018 -C$0.12 Billion-229.51%
2017 C$85.35 M-160.48%
2016 -C$0.15 Billion216.03%
2015 -C$44.66 Million-52.86%
2014 -C$94.73 Million-18.09%
2013 -C$0.12 Billion55.88%
2012 -C$74.2 Million169.94%
2011 -C$27.49 Million-63.44%
2010 -C$75.17 Million-7.19%
2009 -C$80.99 Million15.91%
2008 -C$69.88 Million83.89%
2007 -C$38 Million78.1%
2006 -C$21.34 Million16%
2005 -C$18.4 Million45.24%
2004 -C$12.67 Million682.42%
2003 -C$1.62 Million1659.12%
2002 -C$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
MannKind Corp
MNKD
C$42.64 M-95.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$31.17 B 2,916.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-C$0.38 Billion-136.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.41 B 1,488.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$12.60 B 1,119.98%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
C$44.88 B 4,242.99%๐Ÿ‡บ๐Ÿ‡ธ USA